← Back to Search

Public Health Intervention Package for Coronavirus

N/A

Waitlist Available

Led By Kathleen Fairfield, MD, DrPH

Research Sponsored by Kathleen Fairfield

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at time of enrollment and every 2 months for up to 12 months (for a total of 7 time points)

Awards & highlights

Study Summary

This trial is testing a public health intervention to make COVID-19 testing more acceptable and accessible to underserved populations in the US who are at a higher risk of acquiring COVID-19.

Eligible Conditions

Coronavirus
COVID-19

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at time of enrollment and every 2 months for up to 12 months (for a total of 7 time points)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at time of enrollment and every 2 months for up to 12 months (for a total of 7 time points)

This trial's timeline: 3 weeks for screening, Varies for treatment, and at time of enrollment and every 2 months for up to 12 months (for a total of 7 time points) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Recommended testing proportion

Secondary outcome measures

COVID-19 Testing Perceptions (Knowledge and Attitudes)

Trial Design

1Treatment groups

Experimental Treatment

Group I: COVID-19 TestingExperimental Treatment1 Intervention

The cohort participants will attend an in-person training on how to take an at-home COVID-19 test and also be provided with five at-home test kits at the training and every other month for a total of 35 kits over the course of a year.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Public Health Intervention Package

2022

N/A

~110

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Kathleen FairfieldLead Sponsor

MaineHealthOTHER

71 Previous Clinical Trials

49,205 Total Patients Enrolled

Kathleen Fairfield, MD, DrPHPrincipal InvestigatorMaineHealth

Media Library

Public Health Intervention Package Clinical Trial Eligibility Overview. Trial Name: NCT05270694 — N/A

Coronavirus Research Study Groups: COVID-19 Testing

Coronavirus Clinical Trial 2023: Public Health Intervention Package Highlights & Side Effects. Trial Name: NCT05270694 — N/A

Public Health Intervention Package 2023 Treatment Timeline for Medical Study. Trial Name: NCT05270694 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the largest possible cohort size for this clinical trial?

"Affirmative, data accessible on clinicaltrials.gov reveals that this research project is actively enrolling subjects. This trial was initially advertised on April 13th 2022 and updated most recently a week later. 150 individuals are expected to join across 3 sites."

Answered by AI

Is this research initiative currently inviting participants?

"Affirmative. The research study, which was first published on April 13th 2022, is actively seeking participants as per information provided on clinicaltrials.gov and the details were recently updated last week."

Answered by AI